Nogapendekin alfa inbakicept with intravesical BCG for non-muscle-invasive bladder cancer with carcinoma in situ that is unresponsive to BCG [ID6582]

  • In development
  • GID-TA11767
  • Expected publication date: 
Nogapendekin alfa (ALT-803) + Intravesical Bacillus Calmette-Guerin (BCG) within its marketing authorisation for treating bladder cancer